Galderma develops, manufactures, and supplies dermatological products, and aesthetic and corrective medical solutions. It focuses on developing products for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis (fungal nail infections), pigmentary disorders, and skin cancer. The company also provides products for skin structure, dry skin, atopic dermatitis, scalp psoriasis and other conditions. The company was founded in 1981 and is headquartered in Lausanne, Switzerland with research and development centers around the world.